跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,117 条关于
“Transcenta Therapeutics”
全部
17,117
临床试验
4,066
药物
3,115
机构
1,123
资讯
8,813
8个月前
Transcenta Therapeutics Partners with EirGenix to License Continuous Biomanufacturing Platform for Affordable Biologics
9天前
Transcenta Licenses HiCB Continuous Bioprocessing Platform to WuXi Biologics in Strategic CMC Collaboration
9个月前
Transcenta's Osemitamab Combination Shows Promising 16.6-Month Median PFS in First-Line Gastric Cancer Trial
上个月
Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer
2年前
Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress
2年前
Osemitamab Plus Nivolumab and CAPOX Shows Encouraging Efficacy in G/GEJ Cancer
3个月前
Inhibrx Reports Positive Phase 1/2 Data for Ozekibart in Colorectal Cancer, Plans FDA Filing for Chondrosarcoma
去年
Lupus Nephritis Pipeline Shows Strong Activity with 35+ Companies Developing 40+ Investigational Therapies
去年
IgA Nephropathy Pipeline Shows Robust Growth with 30+ Therapies in Development
去年
Gastric Cancer Pipeline Shows Robust Growth with 220+ Therapies in Development Across 200+ Companies
第 1 页,共 882 页
上一页
下一页